Linalool attenuates acquisition and reinstatement and accelerates the extinction of nicotine-induced conditioned place preference in male mice

References

• Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiat. 2016;3:760–73. doi:10.1016/S2215-0366(16)00104-8.
   PubMed Web of Science ®Google Scholar
• Ferguson TF, Beauchamp A, Rosen EM, Ray AN, Theall KP, Gilpin NW, Molina PE, Edwards S. Pilot study of the adaptation of an alcohol, tobacco, and illicit drug use intervention for vulnerable urban young adults. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00314.
   PubMed Web of Science ®Google Scholar
• Acion L. Methods in addiction research section: notes from the associate editor. Am J Drug Alcohol Abuse. 2017;43:491. doi:10.1080/00952990.2017.1334792.
   PubMed Web of Science ®Google Scholar
• Adinoff B, Carmody TJ, Walker R, Donovan DM, Brigham GS, Winhusen TM. Decision-making processes as predictors of relapse and subsequent use in stimulant-dependent patients. Am J Drug Alcohol Abuse. 2016;42:88–97. doi:10.3109/00952990.2015.1106550.
   PubMed Web of Science ®Google Scholar
• D’Souza MS, Markou A. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract. 2011;6:4–16.
   PubMedGoogle Scholar
• D’Souza MS, Markou A. The “stop” and “go” of nicotine dependence: role of GABA and glutamate. Cold Spring Harb Perspect Med. 2013;3. doi:10.1101/cshperspect.a012146.
   PubMed Web of Science ®Google Scholar
• Pogun S. Editorial: nicotine and the nicotinic cholinergic system in health and disease. Curr Neuropharmacol. 2018;16:336–37. doi:10.2174/1570159X1604180501124517.
   PubMed Web of Science ®Google Scholar
• You S, Li X, Xiong J, Zhu X, Zhangsun D, Zhu X, Luo S. α-Conotoxin TxIB: a uniquely selective ligand for α6/α3β2β3 nicotinic acetylcholine receptor attenuates nicotine-induced conditioned place preference in mice. Mar Drugs. 2019;17:490. doi:10.3390/md17090490.
   PubMed Web of Science ®Google Scholar
• Anderson P, Berridge V, Conrod P, Dudley R, Hellman M, Lachenmeier D, Lingford-Hughes A, Miller D, Rehm J, Room R, et al. Reframing the science and policy of nicotine, illegal drugs and alcohol - conclusions of the ALICE RAP Project. F1000Res. 2017;6:289. doi:10.12688/f1000research.10860.1.
   PubMedGoogle Scholar
• Wang LP, Li F, Shen X, Tsien JZ. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PLoS One. 2010;5:e8616. doi:10.1371/journal.pone.0008616.
   PubMed Web of Science ®Google Scholar
• Jain R, Mukherjee K, Balhara YP. The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review. Yonsei Med J. 2008;49:175–88. doi:10.3349/ymj.2008.49.2.175.
   PubMed Web of Science ®Google Scholar
• Biala G, Budzynska B. Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Biochem Behav. 2008;89:116–25. doi:10.1016/j.pbb.2007.12.005.
   PubMed Web of Science ®Google Scholar
• Padula AE, Griffin WC 3rd, Lopez MF, Nimitvilai S, Cannady R, McGuier NS, Chesler EJ, Miles MF, Williams RW, Randall PK, et al. KCNN genes that encode small-conductance Ca2+-activated K+ channels influence alcohol and drug addiction. Neuropsychopharmacol. 2015;40:1928–39. doi:10.1038/npp.2015.42.
   PubMed Web of Science ®Google Scholar
• Matheson J, Le Foll B. Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) agonists in substance use disorders: a synthesis of preclinical and human evidence. Cells. 2020;9:1196. doi:10.3390/cells9051196.
   PubMed Web of Science ®Google Scholar
• Kotagale NR, Walke S, Shelkar GP, Kokare DM, Umekar MJ, Taksande BG. Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system. Behav Brain Res. 2014;262:118–24. doi:10.1016/j.bbr.2014.01.004.
   PubMed Web of Science ®Google Scholar
• Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF, Story GM, Santos AR. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain. 2010;11:1222–29. doi:10.1016/j.jpain.2010.02.022.
   PubMed Web of Science ®Google Scholar
• Gahukar RT. Management of pests and diseases of important tropical/subtropical medicinal and aromatic plants: a review. J Appl Res Med Aromat Plants. 2018;9:1–18. doi:10.1016/j.jarmap.2018.03.002.
   Web of Science ®Google Scholar
• Ceylan S, Yoldas F, Cakici H, Mordogan N, Bayram E. Effects of nitrogen rates on nitrogen accumulation, ascorbic acid and essential oil contents in parsley. Asian J Chem. 2006;18:2113–18.
   Google Scholar
• Celik S, Ozkaya A. Effects of intraperitoneally administered lipoic acid, vitamin E, and linalool on the level of total lipid and fatty acids in guinea pig brain with oxidative stress induced by H2O2. J Biochem Mol Biol. 2002;35:547–52. doi:10.5483/bmbrep.2002.35.6.547.
   PubMedGoogle Scholar
• Linck VM, Da Silva AL, Figueiró M, Caramão EB, Moreno PR, Elisabetsky E. Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice. Phytomedicine. 2010;17:679–83. doi:10.1016/j.phymed.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Seol GH, Kang P, Lee HS, Seol GH. Antioxidant activity of linalool in patients with carpal tunnel syndrome. BMC Neurol. 2016;16:17. doi:10.1186/s12883-016-0541-3.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yu L, Qiu J, Shen B, Wang D, Soromou LW, Feng H. Linalool attenuates lung inflammation induced by Pasteurella multocida via activating Nrf-2 signaling pathway. Int Immunopharmacol. 2014;21:456–63. doi:10.1016/j.intimp.2014.05.030.
   PubMed Web of Science ®Google Scholar
• Sabogal-Guáqueta AM, Posada-Duque R, Cortes NC, Arias-Londoño JD, Cardona-Gómez GP. Changes in the hippocampal and peripheral phospholipid profiles are associated with neurodegeneration hallmarks in a long-term global cerebral ischemia model: attenuation by linalool. Neuropharmacology. 2018;135:555–71. doi:10.1016/j.neuropharm.2018.04.015.
   PubMed Web of Science ®Google Scholar
• Leal-Cardoso JH, Da Silva-alves KS, Ferreira-da-silva FW, Dos Santos-nascimento T, Joca HC, De Macedo FH, De Albuquerque-neto PM, Magalhães PJ, Lahlou S, Cruz JS, et al. Linalool blocks excitability in peripheral nerves and voltage-dependent Na+ current in dissociated dorsal root ganglia neurons. Eur J Pharmacol. 2010;645:86–93. doi:10.1016/j.ejphar.2010.07.014.
   PubMed Web of Science ®Google Scholar
• Vlachou S, Guery S, Froestl W, Banerjee D, Benedict J, Finn MG, Markou A. Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats. Psychopharmacology (Berl). 2011;215:117–28. doi:10.1007/s00213-010-2119-x.
   PubMed Web of Science ®Google Scholar
• Li S, Li Z, Pei L, Le AD, Liu F. The α7nACh-NMDA receptor complex is involved in cue-induced reinstatement of nicotine seeking. J Exp Med. 2012;209:2141–47. doi:10.1084/jem.20121270.
   PubMed Web of Science ®Google Scholar
• Vatanparast J, Bazleh S, Janahmadi M. The effects of linalool on the excitability of central neurons of snail Caucasotachea atrolabiata. Comp Biochem Physiol C Toxicol Pharmacol. 2017;192:33–39. doi:10.1016/j.cbpc.2016.12.004.
   PubMed Web of Science ®Google Scholar
• Jackson A, Bagdas D, Muldoon PP, Lichtman AH, Carroll FI, Greenwald M, Miles MF, Damaj MI. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: implication for nicotine dependence. Neuropharmacology. 2017;118:38–45. doi:10.1016/j.neuropharm.2017.03.005.
   PubMed Web of Science ®Google Scholar
• Re L, Barocci S, Sonnino S, Mencarelli A, Vivani C, Paolucci G, Scarpantonio A, Rinaldi L, Mosca E. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res. 2000;42:177–82. doi:10.1006/phrs.2000.0671.
   PubMed Web of Science ®Google Scholar
• Li X, Semenova S, D’Souza MS, Stoker AK, Markou A. Involvement of glutamatergic and GABAergic systems in nicotine dependence: implications for novel pharmacotherapies for smoking cessation. Neuropharmacology. 2014;76:554–65. doi:10.1016/j.neuropharm.2013.05.042.
   PubMed Web of Science ®Google Scholar
• Yararbas G, Keser A, Kanit L, Pogun S. Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors. Neuropharmacology. 2010;58:374–82. doi:10.1016/j.neuropharm.2009.10.001.
   PubMed Web of Science ®Google Scholar
• Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol. 2009;19:487–98. doi:10.1016/j.euroneuro.2009.01.007.
   PubMed Web of Science ®Google Scholar
• Le Foll B, Di Ciano P, Panlilio LV, Goldberg SR, Ciccocioppo R. Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence. Curr Drug Targets. 2013;14:768–76. doi:10.2174/1389450111314070006.
   PubMed Web of Science ®Google Scholar
• Panlilio LV, Justinova Z, Goldberg SR. Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther. 2013;138:84–102.
   PubMed Web of Science ®Google Scholar
• Kutlu MG, Connor DA, Tumolo JM, Cann C, Garrett B, Gould TJ. Nicotine modulates contextual fear extinction through changes in ventral hippocampal GABAergic function. Neuropharmacology. 2018;141:192–200. doi:10.1016/j.neuropharm.2018.08.019.
   PubMed Web of Science ®Google Scholar
• Aguilar MA, Rodríguez-Arias M, Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev. 2009;59:253–77. doi:10.1016/j.brainresrev.2008.08.002.
   PubMed Web of Science ®Google Scholar
• Blanco-Gandía MC, Aguilar MA, Miñarro J, Rodríguez-Arias M. Reinstatement of drug-seeking in mice using the conditioned place preference paradigm. J Vis Exp. 2018. doi:10.3791/56983.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh H, Imenshahidi M, Hosseini M, Razavi BM. Effect of linalool on morphine tolerance and dependence in mice. Phytother Res. 2012;26:1399–404. doi:10.1002/ptr.3736.
   PubMed Web of Science ®Google Scholar
• Pourtaqi N, Imenshahidi M, Razavi BM, Hosseinzadeh H. Effect of linalool on the acquisition and reinstatement of morphine-induced conditioned place preference in mice. Avicenna J Phytomed. 2017;7:242–49.
   PubMed Web of Science ®Google Scholar
• Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, et al. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Br J Pharmacol. 2013;168:835–49. doi:10.1111/j.1476-5381.2012.02204.x.
   PubMed Web of Science ®Google Scholar
• Napier TC, Herrold AA, De Wit H. Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev. 2013;37:2081–86. doi:10.1016/j.neubiorev.2013.05.002.
   PubMed Web of Science ®Google Scholar
• Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol. 2007;12:227–462.
   PubMed Web of Science ®Google Scholar
• Shram MJ, Lê AD. Adolescent male Wistar rats are more responsive than adult rats to the conditioned rewarding effects of intravenously administered nicotine in the place conditioning procedure. Behav Brain Res. 2010;206:240–44. doi:10.1016/j.bbr.2009.09.018.
   PubMed Web of Science ®Google Scholar
• Titomanlio F, Perfumi M, Mattioli L. Rhodiola rosea L. extract and its active compound salidroside antagonized both induction and reinstatement of nicotine place preference in mice. Psychopharmacology (Berl). 2014;231:2077–86. doi:10.1007/s00213-013-3351-y.
   PubMed Web of Science ®Google Scholar
• Yusoff NH, Mansor SM, Müller CP, Hassan Z. Baclofen blocks the acquisition and expression of mitragynine-induced conditioned place preference in rats. Behav Brain Res. 2018;345:65–71. doi:10.1016/j.bbr.2018.02.039.
   PubMed Web of Science ®Google Scholar
• Mattioli L, Titomanlio F, Perfumi M. Effects of a Rhodiola rosea L. extract on the acquisition, expression, extinction, and reinstatement of morphine-induced conditioned place preference in mice. Psychopharmacology (Berl). 2012;221:183–93. doi:10.1007/s00213-012-2686-0.
   PubMed Web of Science ®Google Scholar
• Zarrindast MR, Bahreini T, Adl M. Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav. 2002;73:941–49. doi:10.1016/S0091-3057(02)00951-6.
   PubMed Web of Science ®Google Scholar
• Philibin SD, Cameron AJ, Schlumbohm JP, Metten P, Crabbe JC. Ethanol withdrawal-induced motor impairment in mice. Psychopharmacology (Berl). 2012;220:367–78. doi:10.1007/s00213-011-2483-1.
   PubMed Web of Science ®Google Scholar
• Lu L, Liu Y, Zhu W, Shi J, Liu Y, Ling W, Kosten TR. Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse. 2009;35:1–11. doi:10.1080/00952990802455469.
   PubMed Web of Science ®Google Scholar
• Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012;3:200–01. doi:10.4103/2231-4040.104709.
   PubMedGoogle Scholar
• Andrade ALM, De Micheli D. Innovations in the treatment of substance addiction. Springer International Publishing. Copyright ©️ 2016.
   Google Scholar
• Pogun S, Yararbas G, Nesil T, Kanit L. Sex differences in nicotine preference. J Neurosci Res. 2017;95:148–62. doi:10.1002/jnr.23858.
   PubMed Web of Science ®Google Scholar
• Biala G, Staniak N, Budzynska B. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch Pharmacol. 2010;381:361–70. doi:10.1007/s00210-010-0498-5.
   PubMed Web of Science ®Google Scholar
• Biala G, Budzynska B. Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. Eur J Pharmacol. 2006;537:85–93. doi:10.1016/j.ejphar.2006.03.017.
   PubMed Web of Science ®Google Scholar
• File SE, Cheeta S, Akanezi C. Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action. Brain Res. 2001;888:311–13. doi:10.1016/S0006-8993(00)03102-4.
   PubMed Web of Science ®Google Scholar
• Fartootzadeh R, Azizi F, Alaei H, Reisi P. Functional crosstalk of nucleus accumbens CB1 and OX2 receptors in response to nicotine-induced place preference. Neurosci Lett. 2019;698:160–64. doi:10.1016/j.neulet.2019.01.027.
   PubMed Web of Science ®Google Scholar
• Sahraei H, Falahi M, Zarrindast MR, Sabetkasaei M, Ghoshooni H, Khalili M. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur J Pharmacol. 2004;503:81–87. doi:10.1016/j.ejphar.2004.08.054.
   PubMed Web of Science ®Google Scholar
• Bisaga A, Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: n-methyl-D-aspartate (NMDA) antagonists. Drug Alcohol Depend. 2000;59:1–15. doi:10.1016/S0376-8716(99)00107-6.
   PubMed Web of Science ®Google Scholar
• Tsukada H, Nishiyama S, Fukumoto D, Sato K, Kakiuchi T, Domino EF. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys. Neuropsychopharmacol. 2005;30:1861–69. doi:10.1038/sj.npp.1300732.
   PubMed Web of Science ®Google Scholar
• Yavas E, Young AM. N-Methyl-d-aspartate modulation of nucleus accumbens dopamine release by metabotropic glutamate receptors: fast cyclic voltammetry studies in rat brain slices in vitro. Acs Chem Neurosci. 2017;8:320–28. doi:10.1021/acschemneuro.6b00397.
   PubMed Web of Science ®Google Scholar
• Elisabetsky E, Brum LF, Souza DO. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine. 1999;6:107–13. doi:10.1016/S0944-7113(99)80044-0.
   PubMed Web of Science ®Google Scholar
• Silva Brum LF, Emanuelli T, Souza DO, Elisabetsky E. Effects of linalool on glutamate release and uptake in mouse cortical synaptosomes. Neurochem Res. 2001;26:191–94. doi:10.1023/A:1010904214482.
   PubMed Web of Science ®Google Scholar
• Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol. 2005;15:219–25. doi:10.1016/j.euroneuro.2004.07.005.
   PubMed Web of Science ®Google Scholar
• Paterson NE, Froestl W, Markou A. The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl). 2004;172:179–86. doi:10.1007/s00213-003-1637-1.
   PubMed Web of Science ®Google Scholar
• Varani AP, Aso E, Moutinho LM, Maldonado R, Balerio GN. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology (Berl). 2014;231:3031–40. doi:10.1007/s00213-014-3469-6.
   PubMed Web of Science ®Google Scholar
• Cline M, Taylor JE, Flores J, Bracken S, McCall S, Ceremuga TE. Investigation of the anxiolytic effects of linalool, a lavender extract, in the male Sprague-Dawley rat. Aana J. 2008;76:47–52.
   PubMedGoogle Scholar
• Milanos S, Elsharif SA, Janzen D, Buettner A, Villmann C. Metabolic products of linalool and modulation of GABA(A) receptors. Front Chem. 2017;5:46. doi:10.3389/fchem.2017.00046.
   PubMed Web of Science ®Google Scholar
• Harada H, Kashiwadani H, Kanmura Y, Kuwaki T. Linalool odor-induced anxiolytic effects in mice. Front Behav Neurosci. 2018;12:241. doi:10.3389/fnbeh.2018.00241.
   PubMed Web of Science ®Google Scholar
• Bitzer ZT, Goel R, Reilly SM, Elias RJ, Silakov A, Foulds J, Muscat J, Richie JP Jr. Effect of flavoring chemicals on free radical formation in electronic cigarette aerosols. Free Radic Biol Med. 2018;120:72–79. doi:10.1016/j.freeradbiomed.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, Clark JB. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem. 1998;70:1366–75. doi:10.1046/j.1471-4159.1998.70041366.x.
   PubMed Web of Science ®Google Scholar
• Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. CNS Neurol Disord Drug Targets. 2013;12:70–77. doi:10.2174/1871527311312010012.
   PubMed Web of Science ®Google Scholar
• Donvito G, Piscitelli F, Muldoon P, Jackson A, Vitale RM, D’Aniello E, Giordano C, Ignatowska-Jankowska BM, Mustafa MA, Guida F, et al. N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice. Neuropharmacology. 2019;148:320–31. doi:10.1016/j.neuropharm.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Jun HJ, Lee JH, Kim J, Jia Y, Kim KH, Hwang KY, Yun EJ, Do KR, Lee SJ. Linalool is a PPARα ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome. J Lipid Res. 2014;55:1098–110. doi:10.1194/jlr.M045807.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Jia Y. The effect of bioactive compounds in tea on lipid metabolism and obesity through regulation of peroxisome proliferator-activated receptors. Curr Opin Lipidol. 2015;26:3–9. doi:10.1097/MOL.0000000000000145.
   PubMed Web of Science ®Google Scholar
• Rigano D, Sirignano C, Taglialatela-Scafati O. The potential of natural products for targeting PPARα. Acta Pharm Sin B. 2017;7:427–38. doi:10.1016/j.apsb.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Ma L, Wu YM, Guo YY, Yang Q, Feng B, Song Q, Liu SB, Zhao DQ, Zhao MG. Nicotine addiction reduces the large-conductance Ca(2+)-activated potassium channels expression in the nucleus accumbens. Neuromolecular Med. 2013;15:227–37. doi:10.1007/s12017-012-8213-y.
   PubMed Web of Science ®Google Scholar
• Peana AT, De Montis MG, Nieddu E, Spano MT, D’Aquila PS, Pippia P. Profile of spinal and supra-spinal antinociception of (-)-linalool. Eur J Pharmacol. 2004;485:165–74. doi:10.1016/j.ejphar.2003.11.066.
   PubMed Web of Science ®Google Scholar
• Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, London ED. Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. Psychopharmacology. 2018;235:193–202. doi:10.1007/s00213-017-4755-x.
   PubMed Web of Science ®Google Scholar
• Allahverdiyev O, Nurten A, Enginar N. Assessment of rewarding and reinforcing properties of biperiden in conditioned place preference in rats. Behav Brain Res. 2011;225:642–45. doi:10.1016/j.bbr.2011.07.050.
   PubMed Web of Science ®Google Scholar